Matthew Perrone
ABC12WJRT
Washington, DC, United States
Contact Matthew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matthew:
Abbott says agreement reached to reopen baby formula plant
After production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores. The Biden administration has come under intense pressure over the → Read More
FDA OKs another Pfizer, Moderna COVID booster for 50 and up
U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine. → Read More
FDA expands COVID boosters to all adults, final hurdle ahead
Pfizer and Moderna announced Friday the Food and Drug Administration’s decision after at least 10 states already had started offering boosters to all adults. → Read More
Pfizer says COVID-19 pill cut hospital, death risk by 90%
Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months. → Read More
LIVE: White House COVID response briefing; Pfizer says vaccine more than 90% effective in kids
Details of the study were posted online Friday as U.S. regulators consider opening vaccinations to youngsters 5 to 11. → Read More
FDA approves mixing COVID vaccines; backs Moderna, J&J boosters
The FDA’s Doran Fink previewed “some announcements later today,” which were expected to include allowing the mixing and matching of COVID-19 booster doses among the three U.S. manufacturers — Pfizer, Moderna and J&J. Fink appeared at a meeting of vaccine experts convened by the Centers for Disease Control and Prevention, who are expected to take up the FDA decisions and make their own… → Read More
FDA panel debates Moderna, J&J COVID shots for booster
Thursday, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine. → Read More
FDA authorizes first e-cigarettes, cites benefit for smokers
Heath officials have authorized the first electronic cigarettes in the U.S., saying the R.J. Reynolds vaping products can benefit adult smokers. → Read More
Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines
On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra doses of the two vaccines should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week. → Read More
J&J seeks US clearance for COVID-19 vaccine booster doses
J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company’s one-shot vaccine. While the company said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators. → Read More
Merck says experimental pill cuts worst effects of COVID-19
If cleared, Merck’s drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection. → Read More
FDA experts among group opposing US booster shot plan
The experts reviewed studies of the vaccines’ performance and concluded the shots are working well despite the extra-contagious delta variant, especially against severe disease. → Read More
COVID-19 surge in the US: The summer of hope ends in gloom
The delta variant is filling hospitals, sickening alarming numbers of children and driving coronavirus deaths in some places to the highest levels of the entire pandemic. → Read More
US health officials call for booster shots against COVID-19
The plan, as outlined by the director of the Centers for Disease Control and Prevention and other top authorities, calls for an extra dose eight months after people get their second shot of the Pfizer or Moderna vaccine. The doses could begin the week of Sept. 20. → Read More
More protection: US likely to authorize COVID booster shots
The move is being driven by both the highly contagious variant and preliminary evidence that the vaccine’s protective effect starts dropping within months. → Read More
Extra COVID vaccine OK’d for those with weak immune systems
U.S. health regulators have authorized an extra dose of the COVID-19 vaccines in people with weakened immune systems to better protect them from the virus. → Read More
Do I need to get tested for COVID-19 if I’m vaccinated?
The COVID-19 vaccines are still very good at protecting people from getting seriously ill, but the CDC says new data shows vaccinated people infected with the delta variant could spread it to others. → Read More
FDA trims use of contentious Alzheimer’s drug amid backlash
The Food and Drug Administration said the change is intended to address confusion among physicians and patients about who should get the drug, which has faced an intense public backlash since its approval last month. → Read More
FDA approves much-debated Alzheimer’s drug panned by experts
The Food and Drug Administration said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer’s patients. → Read More
FDA says single-dose shot from J&J prevents severe COVID
The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. → Read More